Effect of Palm and LI4 (Hegu) Acupressure on Labor Pain, Labor Duration and Satisfaction
The Effect of Palm and LI4 Acupressure Applications During Labor on Labor Pain, Duration and Satisfaction: A Randomized Controlled Trial
This randomized controlled trial aims to evaluate the effects of palm (hand point) pressure and LI4 (Hegu) acupressure applied during labor on labor pain, duration of labor, and maternal birth satisfaction. A total of 105 nulliparous women aged 18-35 years with a term, low-risk, singleton pregnancy in spontaneous labor will be randomly assigned to three groups of 35: a palm pressure group, an LI4 acupressure group, and a control group receiving routine labor care. In the palm group, women press a wooden comb into their own palm during contractions. In the LI4 group, the researcher applies pressure to the LI4 point during contractions using an Electronic Acupuncture Pen and Meridian Massage Device. Applications are performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Pain is measured with a Visual Analog Scale and an observer-rated pain expression scale (ESVADOPA) before and 30 minutes after each application. Duration of labor and neonatal Apgar scores are recorded, and birth satisfaction is assessed within 4 hours after birth. The study is conducted in a single center in Gaziantep, Türkiye.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Aged 18-35 years
- Able to read, write and understand Turkish
- Nulliparous woman with a term pregnancy (37-42 weeks of gestation)
- Singleton, live fetus in vertex presentation
- Spontaneous onset of labor
- Cervical dilatation of 4 cm or more
- Estimated fetal weight of 2500-4000 g confirmed by ultrasound by a physician
- No risk factors in obstetric and medical history (low-risk pregnancy)
- Willing to participate and gives written informed consent
Exclusion Criteria:
- Multiple pregnancy
- Pregnancy achieved by in vitro fertilization (IVF)
- Complicated pregnancy (e.g., gestational diabetes, hypertensive disorders)
- Previous cesarean delivery
- Presentation anomaly
- Induction of labor
- Neurological, psychiatric or communication-impairing disease
- Use of, or planned use of, another pain-relief method (e.g., hot/cold application, TENS, aromatherapy, massage)
- Structural or chromosomal fetal anomaly
- Obesity according to the World Health Organization classification (BMI 30 kg/m2 or higher)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Palm Pressure Group
Women apply pressure with a curved wooden comb to their own palm (Lao Gong point) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, under the supervision of the researcher. Routine labor care continues. |
Palm Pressure Group: A curved wooden comb is pressed by the woman into her own palm (Lao Gong point) during contractions. After the researcher demonstrates the technique, pressure is applied for six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions.
Andere Namen:
|
|
Experimental: LI4 Acupressure Group
The researcher locates the LI4 (Hegu) point with an Electronic Acupuncture Pen and Meridian Massage Device and applies pressure (about 3-5 kg of force) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Routine labor care continues. |
The researcher locates the LI4 (Hegu) point on the back of the hand with an Electronic Acupuncture Pen and Meridian Massage Device, which signals the point by light and sound. Pressure (about 3-5 kg of force) is then applied with the device. The application is performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions. |
|
Kein Eingriff: Control Group
Women receive routine midwifery care in the delivery room with no additional intervention. Pain measurements are made at the same dilatation stages as in the other groups. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Labor pain intensity measured by Visual Analog Scale (VAS)
Zeitfenster: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor
|
Women rate the pain felt after a contraction on a vertical Visual Analog Scale from 0 (no pain) to 10 (severe pain). The mark is measured with a ruler and recorded as the pain score. Higher scores indicate more pain. |
Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Pain expression measured by the Rating Scale of Pain Expression during Childbirth (ESVADOPA)
Zeitfenster: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor
|
An independent observer who is unaware of group allocation rates pain expression during contractions with ESVADOPA. The scale has 6 items (facial muscles, body response, verbal response, restlessness, ability to relax, vegetative symptoms), each scored 0-3. Total scores range from 0 to 18; higher scores indicate more pain expression. |
Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor
|
|
Duration of labor
Zeitfenster: From admission to the delivery room until delivery of the placenta (during labor and birth)
|
Duration of labor stages calculated in minutes from times recorded on the labor follow-up form: admission to the delivery room, start and end of the second stage, and delivery of the placenta. |
From admission to the delivery room until delivery of the placenta (during labor and birth)
|
|
Birth satisfaction measured by the Birth Satisfaction Scale
Zeitfenster: Within 4 hours after birth
|
Women complete the 10-item Birth Satisfaction Scale (Turkish version), rated on a 5-point Likert scale (0-4), with reverse scoring for 4 items. Total scores range from 0 to 40; higher scores indicate greater birth satisfaction. |
Within 4 hours after birth
|
|
Neonatal Apgar score
Zeitfenster: 1 minute and 5 minutes after birth
|
Apgar scores of the newborn, recorded on the labor follow-up form. Scores range from 0 to 10; higher scores indicate a better condition of the newborn. |
1 minute and 5 minutes after birth
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 2026/64
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .